Cytosens

Cytosens is a private, revenue-generating company that functions as a distributor and service provider for advanced life science research tools. Its business model centers on aggregating and providing access to cutting-edge international technologies in omics, cytometry, 3D cell culture, and molecular biology, complemented by a strong portfolio of custom laboratory services like oligonucleotide synthesis and sequencing. The company aims to become a comprehensive technology hub for the Italian research community, leveraging a growing sales network and a team of application specialists to offer tailored support. Its focus is on enabling research in oncology and immunology through product distribution and outsourced scientific services.

Curated aggregation and distribution of cutting-edge life science research technologies (cytometry, molecular biology, spatial biology, 3D cell culture) combined with a comprehensive suite of outsourced laboratory services (sequencing, oligo synthesis, proteomics). Differentiated by a team of application specialists providing tailored scientific and technical support.

Operates in the competitive life science distribution and research services market. Faces competition from global giants (e.g., Thermo Fisher Scientific, Merck KGaA) with vast portfolios, as well as other regional distributors and specialized service providers in Italy. Differentiation is achieved through deep technical support, curated technology selection, and an integrated product-service model.